Stockscreener 앱 받기
7.6205
4.69%
-0.3795
전일 마감가:
$8.00
열려 있는:
$8.16
하루 거래량:
529.31K
Relative Volume:
0.27
시가총액:
$927.33M
수익:
-
순이익/손실:
$-29.07M
주가수익비율:
-26.28
EPS:
-0.29
순현금흐름:
$-31.85M
1주 성능:
+1.80%
1개월 성능:
-0.20%
6개월 성능:
+68.69%
1년 성능:
+158.47%
1일 변동 폭
$7.60
$8.1609
1주일 범위
$7.23
$8.78
52주 변동 폭
$2.36
$8.78
트레비 테라퓨틱스 Stock (TRVI) Company Profile
명칭
Trevi Therapeutics Inc
전화
203-304-2499
주소
195 CHURCH STREET, NEW HAVEN, CT
TRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
7.615 | 903.58M | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.07 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.07 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.47 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
704.77 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.45 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
트레비 테라퓨틱스 Stock (TRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 재확인 | Needham | Buy |
| 2025-03-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-30 | 개시 | Raymond James | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-12 | 개시 | B. Riley Securities | Buy |
| 2022-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | BMO Capital Markets | Outperform |
| 2019-06-03 | 개시 | Needham | Buy |
| 2019-06-03 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | Stifel | Buy |
모두보기
트레비 테라퓨틱스 주식(TRVI)의 최신 뉴스
Will Trevi Therapeutics Inc. stock go up soon2025 Key Highlights & Weekly Setup with ROI Potential - Newser
Visualizing Trevi Therapeutics Inc. stock with heatmaps2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
Is Trevi Therapeutics Inc. stock reversal real or fakeJuly 2025 Outlook & Consistent Profit Alerts - Newser
IPF Drug Developer Trevi Therapeutics Set for Major Conference Circuit Including ERS Congress 2025 - Stock Titan
Will Trevi Therapeutics Inc. rebound enough to break even2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Why Trevi Therapeutics Inc. is moving todayWeekly Investment Report & Stock Portfolio Risk Management - Newser
Signal strength of Trevi Therapeutics Inc. stock in tech scannersProfit Target & Risk Controlled Stock Alerts - Newser
Full technical analysis of Trevi Therapeutics Inc. stockEarnings Growth Summary & Entry Point Strategy Guides - Newser
What to expect from Trevi Therapeutics Inc. in the next 30 daysWeekly Investment Report & Free Low Drawdown Momentum Trade Ideas - Newser
What Fibonacci levels say about Trevi Therapeutics Inc. reboundJuly 2025 Highlights & Community Supported Trade Ideas - Newser
Sentiment analysis tools applied to Trevi Therapeutics Inc.Market Volume Report & Growth Focused Investment Plans - Newser
Tools to assess Trevi Therapeutics Inc.’s risk profileWatch List & Daily Market Momentum Tracking - Newser
What data driven models say about Trevi Therapeutics Inc.’s futureQuarterly Market Summary & High Return Stock Watch Alerts - Newser
Multi asset correlation models including Trevi Therapeutics Inc.2025 Technical Patterns & Weekly Return Optimization Plans - Newser
Trevi stock up as B. Riley cites deal prospects (TRVI:NASDAQ) - Seeking Alpha
Trevi Therapeutics (TRVI.O) Sees Sharp Intraday Move — But No Clear Technical Signal, So What's Driving It? - AInvest
Statistical indicators supporting Trevi Therapeutics Inc.’s strengthJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
Tick level data insight on Trevi Therapeutics Inc. volatility2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
Will Trevi Therapeutics Inc. price bounce be sustainable2025 Market Trends & Community Supported Trade Ideas - Newser
What’s next for Trevi Therapeutics Inc. stock priceQuarterly Performance Summary & Daily Chart Pattern Signals - Newser
Volatility clustering patterns for Trevi Therapeutics Inc.July 2025 Update & AI Forecast Swing Trade Picks - Newser
Trevi Therapeutics Inc. stock trendline breakdownMarket Risk Report & Weekly High Return Stock Opportunities - Newser
Can volume confirm reversal in Trevi Therapeutics Inc.Gold Moves & Weekly Chart Analysis and Guides - Newser
Applying chart zones and confluence areas to Trevi Therapeutics Inc.Market Movement Recap & Free Weekly Watchlist of Top Performers - Newser
How institutional ownership impacts Trevi Therapeutics Inc. stockWeekly Trade Analysis & Scalable Portfolio Growth Ideas - Newser
Published on: 2025-08-26 09:21:24 - Newser
Has Trevi Therapeutics Inc. found a price floor2025 Trading Recap & Risk Controlled Swing Alerts - Newser
Key metrics from Trevi Therapeutics Inc.’s quarterly dataWeekly Profit Report & Verified Entry Point Detection - Newser
Market reaction to Trevi Therapeutics Inc.’s recent newsJuly 2025 Closing Moves & High Accuracy Trade Alerts - Newser
Using Ichimoku Cloud for Trevi Therapeutics Inc. technicalsBull Run & Risk Managed Trade Strategies - Newser
Using data tools to time your Trevi Therapeutics Inc. exitEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-08-25 02:43:15 - Newser
Breakout Zone: Can Trevi Therapeutics Inc. outperform in the next rallyCEO Change & Smart Swing Trading Techniques - sundaytimes.kr
Can Trevi Therapeutics Inc. rally from current levelsEarnings Summary Report & Free Community Consensus Stock Picks - Newser
Trend analysis for Trevi Therapeutics Inc. this weekQuarterly Trade Report & Community Verified Swing Trade Signals - Newser
Real time breakdown of Trevi Therapeutics Inc. stock performance2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser
트레비 테라퓨틱스 (TRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
트레비 테라퓨틱스 주식 (TRVI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Option Exercise |
1.43 |
2,631 |
3,762 |
224,004 |
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Sale |
6.60 |
2,631 |
17,365 |
221,373 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Option Exercise |
1.43 |
5,263 |
7,526 |
218,576 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Sale |
6.58 |
5,263 |
34,625 |
213,313 |
1.25%
0.61%
자본화:
|
볼륨(24시간):